1. Home
  2. PLRX vs MPB Comparison

PLRX vs MPB Comparison

Compare PLRX & MPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • MPB
  • Stock Information
  • Founded
  • PLRX 2015
  • MPB 1868
  • Country
  • PLRX United States
  • MPB United States
  • Employees
  • PLRX N/A
  • MPB N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • MPB Major Banks
  • Sector
  • PLRX Health Care
  • MPB Finance
  • Exchange
  • PLRX Nasdaq
  • MPB Nasdaq
  • Market Cap
  • PLRX 89.0M
  • MPB 691.1M
  • IPO Year
  • PLRX 2020
  • MPB N/A
  • Fundamental
  • Price
  • PLRX $1.46
  • MPB $30.71
  • Analyst Decision
  • PLRX Hold
  • MPB Buy
  • Analyst Count
  • PLRX 10
  • MPB 2
  • Target Price
  • PLRX $3.93
  • MPB $34.50
  • AVG Volume (30 Days)
  • PLRX 692.5K
  • MPB 82.5K
  • Earning Date
  • PLRX 11-06-2025
  • MPB 10-22-2025
  • Dividend Yield
  • PLRX N/A
  • MPB 2.60%
  • EPS Growth
  • PLRX N/A
  • MPB N/A
  • EPS
  • PLRX N/A
  • MPB 2.30
  • Revenue
  • PLRX N/A
  • MPB $191,454,000.00
  • Revenue This Year
  • PLRX N/A
  • MPB $24.57
  • Revenue Next Year
  • PLRX N/A
  • MPB $12.23
  • P/E Ratio
  • PLRX N/A
  • MPB $13.35
  • Revenue Growth
  • PLRX N/A
  • MPB 13.34
  • 52 Week Low
  • PLRX $1.10
  • MPB $22.50
  • 52 Week High
  • PLRX $16.10
  • MPB $33.87
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 40.86
  • MPB 66.81
  • Support Level
  • PLRX $1.66
  • MPB $29.94
  • Resistance Level
  • PLRX $1.85
  • MPB $30.44
  • Average True Range (ATR)
  • PLRX 0.12
  • MPB 0.60
  • MACD
  • PLRX -0.03
  • MPB -0.02
  • Stochastic Oscillator
  • PLRX 2.27
  • MPB 79.70

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About MPB Mid Penn Bancorp

Mid Penn Bancorp Inc operates in the financial services domain. It conducts commercial banking and trust business in the United States. Its range of services comprises mortgage and home equity loans, secured and unsecured consists and consumer loans, lines of credit, construction financing, farm loans, community development, local government loans, and various types of time and demand deposits.

Share on Social Networks: